PL431978A1 - Application of prochlorperazine and/or its pharmacologically permissable salts in the treatment of Candida mycoses and Saccharomyces - Google Patents

Application of prochlorperazine and/or its pharmacologically permissable salts in the treatment of Candida mycoses and Saccharomyces

Info

Publication number
PL431978A1
PL431978A1 PL431978A PL43197819A PL431978A1 PL 431978 A1 PL431978 A1 PL 431978A1 PL 431978 A PL431978 A PL 431978A PL 43197819 A PL43197819 A PL 43197819A PL 431978 A1 PL431978 A1 PL 431978A1
Authority
PL
Poland
Prior art keywords
prochlorperazine
treatment
application
pharmacologically
salts
Prior art date
Application number
PL431978A
Other languages
Polish (pl)
Inventor
Michał Gleńsk
Roman FRANICZEK
Barbara Krzyżanowska
Maciej Włodarczyk
Original Assignee
Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu filed Critical Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Priority to PL431978A priority Critical patent/PL431978A1/en
Publication of PL431978A1 publication Critical patent/PL431978A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest prochlorperazyna i/lub jej farmakologicznie dopuszczalne sole do stosowania w leczeniu lub profilaktyce grzybic.The subject of this application is prochlorperazine and / or its pharmacologically acceptable salts for use in the treatment or prophylaxis of mycoses.

PL431978A 2019-11-27 2019-11-27 Application of prochlorperazine and/or its pharmacologically permissable salts in the treatment of Candida mycoses and Saccharomyces PL431978A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL431978A PL431978A1 (en) 2019-11-27 2019-11-27 Application of prochlorperazine and/or its pharmacologically permissable salts in the treatment of Candida mycoses and Saccharomyces

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL431978A PL431978A1 (en) 2019-11-27 2019-11-27 Application of prochlorperazine and/or its pharmacologically permissable salts in the treatment of Candida mycoses and Saccharomyces

Publications (1)

Publication Number Publication Date
PL431978A1 true PL431978A1 (en) 2021-05-31

Family

ID=76133040

Family Applications (1)

Application Number Title Priority Date Filing Date
PL431978A PL431978A1 (en) 2019-11-27 2019-11-27 Application of prochlorperazine and/or its pharmacologically permissable salts in the treatment of Candida mycoses and Saccharomyces

Country Status (1)

Country Link
PL (1) PL431978A1 (en)

Similar Documents

Publication Publication Date Title
MX2023004037A (en) Bicyclic compounds as allosteric shp2 inhibitors.
MX2022007607A (en) 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors.
CL2019000477A1 (en) A crystalline nor-c21-n-pyrazolyl c3,3-disubstituted steroid.
CO2020015923A2 (en) Gremlin-1 antagonist for the prevention and treatment of cancer
CO2018001296A2 (en) Beta-amino acid ester phosphodiamide ester antiviral compounds
MX2018012390A (en) SELENIUM DYSULPHIDE COMPOSITIONS FOR USE IN THE TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION.
ECSP15018618A (en) NON-NUCLEOSID INHIBITORS OF REVERSE TRANSCRIPTASE
HN2012002039A (en) NON-NUCLEOSIDIC INHIBITORS OF THE REVERSE TRANSCRIPT
MX392313B (en) COMBINATIONS OF A 4-PYRIMIDINSULFAMIDE DERIVATIVE WITH ACTIVE INGREDIENTS FOR THE TREATMENT OF ENDOTHELIN-RELATED DISEASES.
MX386873B (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USES TO TREAT CARDIOVASCULAR DISEASES
MX390051B (en) ANTAGONISTS OF EP4.
MX2022008478A (en) Low-dose brimonidine combinations and uses thereof.
MX2024003655A (en) METHODS FOR TREATING CANCER.
CY1120700T1 (en) TRIAMINOPYRIMIDINE COMPOUNDS USED FOR THE PREVENTION OR TREATMENT OF MATERNITY
UA124939C2 (en) METHOD FOR INCREASING PLASMA CONCENTRATION OF DESOXYURIDINE (dUrd) IN A HUMAN SUBJECT
WO2018094106A3 (en) ALLOSTERIC ANTAGONISTS OF GPRC6a AND THEIR USE IN MITIGATING PROTEINOPATHIES
IT201700025666A1 (en) Composition for use in the treatment of hypercholesterolemia and in the prevention of cardiovascular diseases.
EA202090424A1 (en) BICYCLIC HISTONDEACETYLASE INHIBITORS
PL431978A1 (en) Application of prochlorperazine and/or its pharmacologically permissable salts in the treatment of Candida mycoses and Saccharomyces
EA202090827A1 (en) Oral Compositions for the Treatment of Gastroesophageal Reflux
MX2019008782A (en) SYNERGIC COMPOSITION FOR THE MAINTENANCE OF THE HEALTHY BALANCE OF THE MICROFLORA.
MX2018015208A (en) ANDROGRAPHOLID TO TREAT PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS.
MX2018013031A (en) USE OF AN ACETILCOLINESTERASE AND IDALOPIRDINE INHIBITOR TO REDUCE FALLS IN PATIENTS WITH PARKINSON'S DISEASE.
MX384850B (en) PHARMACEUTICAL COMPOSITIONS OF VAGINAL INSERTED ESTRADIOL AND METHODS.
PL438135A1 (en) Glucose-methotrexate conjugate for use in the prevention or treatment of autoimmune diseases